Form D · Biotechnology

JUVENTAS THERAPEUTICS INC

Cleveland, OH · CIK 0001448342

Offering snapshot reported Oct 4, 2017 · SEC filing

Reported sold
$1.31M
Offering amount: $6M
Investors reported
46
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 22, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 4, 2017Initial$1,311,202No comparison46SEC filing
May 19, 2015Initial$7,386,412No comparison37SEC filing
Nov 20, 2013Initial$5,000,000No comparison45SEC filing
Aug 8, 2012Amendment$22,060,000$10,060,000vs Feb 3, 201235SEC filing
Feb 3, 2012Amendment$12,000,000No comparison34SEC filing
Oct 14, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-295969

Source: Form D, filed Oct 4, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rahul Aras Director, Executive
George Arida Director
James Boland Director
Suzette Dutch Director
George Emont Director
Troy Ignelzi Executive
Jack Miner Director
Roger Newton Director
Marc Penn Director, Executive
Matthew Pollman Director, Executive
Matt Pollman Director
Somu Subramaniam Director
Linda Tufts Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3615 Superior Avenue, Suite 4403 B
Cleveland, OH, 44114